Research Article
Distal Angioplasty in Diabetic Patients: A Two-Year Retrospective Study at Fann University Hospital, Dakar, Senegal
Ndeye Fatou Sow
,
Abdoul Aziz Thiaw*,
Magaye Gaye,
Moussa Diagne,
Abdou Ahat Mbengue,
Amadou Dioulde Diallo,
Papa Adama Dieng
Issue:
Volume 12, Issue 5, October 2026
Pages:
113-121
Received:
28 July 2026
Accepted:
6 August 2026
Published:
2 September 2026
Abstract: Background: Distal angioplasty has become a key therapeutic option for diabetic patients presenting with chronic limb-threatening ischemia (CLTI), particularly in settings where infrapopliteal, diffuse, and calcified lesions are predominant. Despite the growing burden of diabetes in sub-Saharan Africa, regional data remain scarce. Methods: This retrospective, single?center study included all diabetic patients who underwent distal angioplasty at Fann Hospital between January 2021 and December 2022. Clinical characteristics, cardiovascular risk factors, imaging findings, procedural techniques, and postoperative outcomes were analyzed. Results: Eighty-six patients were included (mean age 66.3 ± 7.5 years). Most presented with stage IV ischemia (84.88%). Type 2 diabetes was predominant (95.35%), with a mean duration of 14.3 years. CT angiography revealed multivessel distal disease in nearly all cases. Distal angioplasty was performed under local anesthesia in 96.52% of procedures, with antegrade puncture in 98.8%. A 3mm balloon was used in 87.2% of cases, and stenting was required in only one patient. Residual stenosis occurred in 10.47% of procedures and arterial dissection in 9.3%. Primary wound healing was achieved in 60.81% of patients, with a mean healing time of 4 months. Twenty-six amputations were performed (18 minor, 8 major). Overall mortality reached 17.4%, with hypertension significantly associated with death (p = 0.028). Median survival after angioplasty was 36 days. Conclusion: Distal angioplasty is feasible and effective in diabetic patients with severe lower?limb ischemia, even in resource-limited settings. However, high mortality highlights the need for comprehensive cardiovascular management, early PAD detection, and strengthened multidisciplinary care pathways to improve long-term outcomes.
Abstract: Background: Distal angioplasty has become a key therapeutic option for diabetic patients presenting with chronic limb-threatening ischemia (CLTI), particularly in settings where infrapopliteal, diffuse, and calcified lesions are predominant. Despite the growing burden of diabetes in sub-Saharan Africa, regional data remain scarce. Methods: This ret...
Show More
Research Article
Clinical Profile and Etiological Spectrum of Exudative Pleural Effusion
Collins Osaro Iyamu*,
Stanley Ukadike Okugbo
Issue:
Volume 12, Issue 5, October 2026
Pages:
122-130
Received:
8 August 2026
Accepted:
24 August 2026
Published:
18 September 2026
DOI:
10.11648/j.ijcts.20261205.12
Downloads:
Views:
Abstract: Background: Exudative pleural effusion is commonly caused by tuberculosis and malignancies, often presenting significant diagnostic challenges in clinical practice. The need to combine clinical characteristics with a cost effective and targeted approach towards making a definitive diagnosis cannot be overemphasized. This study examines the clinical presentation, demographic characteristics, and etiological spectrum of exudative pleural effusion in a Nigerian tertiary care setting. Methods: This prospective study involved 58 patients, aged 19 to 87 years who were referred to the cardiothoracic unit of the University of Benin Teaching Hospital over a period of one year with undiagnosed exudative pleural effusion. The demographics, clinical presentation and investigations including laboratory, radiological and pleural fluid characteristics were recorded. The data were subsequently analyzed using SPSS version 25, with results expressed as frequencies, percentages, means, and standard deviations. Results: The study revealed malignancy (50%) and tuberculosis (43.2%) as the leading causes of undiagnosed exudative pleural effusion in our environment. Dyspnea (91.4%), cough (87.9%), and chest pain (79.3%) were the most common symptoms. It also demonstrated male preponderance with a male to female ratio of 1.1:1 and a mean age of 51.16±17.487. Left sided effusion predominates (56.9%) as compared to the right (43.1%). Hemorrhagic effusion featured prominently in cases of malignancy (82.8%) while turbid effusion was commoner in cases of tuberculosis (72.0%). Conclusion: These findings highlight the need for a thorough clinical evaluation and targeted diagnostic strategies to optimize patient outcomes.
Abstract: Background: Exudative pleural effusion is commonly caused by tuberculosis and malignancies, often presenting significant diagnostic challenges in clinical practice. The need to combine clinical characteristics with a cost effective and targeted approach towards making a definitive diagnosis cannot be overemphasized. This study examines the clinical...
Show More
